NCCN Foundation Celebrates 2025 Young Investigator Award Recipients Shaping the Future of Cancer Research [Yahoo! Finance]
Exelixis, Inc. (EXEL)
Last exelixis, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-mediaresources
Company Research
Source: Yahoo! Finance
April 3, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network ® (NCCN ® ) and the NCCN Foundation ® proudly announce four recipients for the 2025 NCCN Foundation Young Investigator Awards ( YIA ). These awards provide essential funding for promising up-and-coming researchers at NCCN Member Institutions, supporting studies that aim to improve cancer care. Each recipient will receive up to in funding over two years, with oversight provided through the NCCN Oncology Research Program ( ORP "Early-career researchers bring fresh perspectives to some of the most complex challenges in cancer care," said Crystal S. Denlinger , MD, Chief Executive Officer, NCCN —a former NCCN Foundation YIA recipient. "Supporting these investigators and their work is critical for advancing cancer treatment and outcomes. This program is an investment in their potential—and in the discoveries that will improve cancer outcomes in the future." The 2025 NCCN Foundation Young Investigator Awardees are:
Show less
Read more
Impact Snapshot
Event Time:
EXEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXEL alerts
High impacting Exelixis, Inc. news events
Weekly update
A roundup of the hottest topics
EXEL
News
- Exelixis (NASDAQ:EXEL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Exelixis (NASDAQ:EXEL) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=EXEL&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> fMarketBeat
- Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D Day Transcript [Seeking Alpha]Seeking Alpha
- Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025Business Wire
- Exelixis (NASDAQ:EXEL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
EXEL
Earnings
- 11/4/25 - Beat
EXEL
Sec Filings
- 12/12/25 - Form 144
- 12/5/25 - Form 4
- 11/26/25 - Form 4
- EXEL's page on the SEC website